Sector: MedicalArQule, Inc. (NASDAQ: ARQL)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 179 |
Technical : | 299 |
Performance : | 298 |
Overall: | 294 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 179 |
Technical : | 305 |
Performance : | 302 |
Overall: | 295 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 176 |
Technical : | 229 |
Performance : | 303 |
Overall: | 283 |
Number of Stocks: | 306 |
Headlines
- Drug Discovery Capabilities of ArQule Kinase Inhibitor Platform Presented at AACR-NCI-EORTC Conference
Nov 16, 2009 12:30 PM | ARQL
- ArQule, Inc. to Present at Lazard Capital Markets Sixth Annual Healthcare Conference on November 17, 2009
Nov 10, 2009 08:30 AM | ARQL
- ArQule Announces Third Quarter Fiscal 2009 Results
Nov 05, 2009 07:01 AM | ARQL
- ArQule, Inc. to Report Third Quarter 2009 Financial Results on Thursday, November 5, 2009
Oct 29, 2009 08:30 AM | ARQL
- ArQule, Inc. to Present at Oppenheimer 20th Annual Healthcare Conference on November 3, 2009
Oct 27, 2009 04:00 PM | ARQL
- ArQule to Introduce Novel FGFR Inhibitor Program Discovered Through Its Proprietary Kinase Inhibitor Platform at AACR-NCI-EORTC Conference
Oct 15, 2009 08:44 AM | ARQL
- European Medicines Evaluation Agency Grants Orphan Drug Designation to ARQ 197 for Treatment of Soft Tissue Sarcoma
Oct 14, 2009 08:30 AM | ARQL
- StockPreacher.com Issues Trading Overview for Oncolytics Biotech Inc.
Oct 07, 2009 06:52 AM | AGEN, ARQL, INFI, ONCY, SUPG
- CORRECTING and REPLACING ArQule Provides Clinical Update on ARQ 197
Oct 05, 2009 08:45 AM | ARQL
- ArQule Provides Clinical Update on ARQ 197
Oct 05, 2009 08:30 AM | ARQL
- Cytokinetics Announces Addition to Board of Directors
Nov 06, 2009 07:51 AM | AMGN, ARQL, CYTK
- ArQule Reports Second Quarter 2009 Financial Results
Aug 06, 2009 07:09 AM | ARQL
- ArQule, Inc. to Report Second Quarter 2009 Financial Results on Thursday, August 6, 2009
Jul 30, 2009 08:46 AM | ARQL
- ArQule, Inc. to Present at BMO Capital Markets 9th Annual Focus on Healthcare Conference on August 5, 2009
Jul 29, 2009 08:47 AM | ARQL
- ArQule, Inc. to Present at 8th Annual Needham Life Sciences Conference on June 10, 2009
Jun 03, 2009 08:52 AM | ARQL
- ASCO Presentations Highlight Findings from Clinical Trials with ArQule’s c-MET Inhibitor, ARQ 197
Jun 01, 2009 07:03 AM | ARQL
- CORRECTING and REPLACING ArQule, Inc. to Present at Leerink Swann Cancer Roundtable on May 20, 2009
May 15, 2009 03:10 PM | ARQL
- ArQule, Inc. to Present at Leerink Swann Cancer Roundtable on May 20, 2009
May 13, 2009 11:01 AM | ARQL
- ArQule Reports First Quarter 2009 Financial Results
May 07, 2009 07:08 AM | ARQL
- ArQule, Inc. to Report First Quarter 2009 Financial Results on Thursday, May 7, 2009
Apr 30, 2009 08:32 AM | ARQL
- Form 4 ARQULE INC For: Nov 18 Filed by: LOBERG MICHAEL D (10K)
Nov 20, 2009 12:01 PM
- Form 4 ARQULE INC For: Nov 18 Filed by: BARABE TIMOTHY C (10K)
Nov 20, 2009 11:54 AM
- Form 4 ARQULE INC For: Nov 12 Filed by: Pucci Paolo (10K)
Nov 13, 2009 11:05 AM
- Form 4 BARABE TIMOTHY C For: Oct 28 (10K)
Oct 30, 2009 12:21 PM
- Form 4 ARQULE INC For: Oct 26 Filed by: LOBERG MICHAEL D (10K)
Oct 27, 2009 03:17 PM
- Form 4 ARQULE INC For: Sep 23 Filed by: LOBERG MICHAEL D (10K)
Sep 25, 2009 12:17 PM
- Form 4 BARABE TIMOTHY C For: Sep 23 (10K)
Sep 25, 2009 12:09 PM
- Form 4 ARQULE INC For: Sep 17 Filed by: LAMPERT MARK N (10K)
Sep 21, 2009 10:09 AM
- Form 4 ARQULE INC For: Aug 28 Filed by: LOBERG MICHAEL D (10K)
Sep 01, 2009 01:13 PM
- Form 4 BARABE TIMOTHY C For: Aug 28 (10K)
Sep 01, 2009 01:13 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ARQL
|
Compare to S&P
|
| YTD |
-19.67 %
|
-33.64 %
|
| 4 Weeks |
-19.67 %
|
-20.09 %
|
| 12 Weeks |
-43.31 %
|
-46.80 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 13.64 %
|
|
EPS Growth in Last Year: 26.92 %
|
|
Sales Growth in Last Quarter: 6.27 %
|
|
Sales Growth in Last Quarter: 141.59 %
|
|
